Psychotropic Medication Use in United States Pediatric Emergency Department Visits
Copyright © 2022 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved..
OBJECTIVE AND BACKGROUND: Little is known about pediatric psychotropic medication use in the emergency department (ED), despite a rise in mental and behavioral health visits. This study describes psychotropic medication use in a nationally representative sample of pediatric mental and behavioral health ED visits over a 14-year period.
METHODS: We conducted a cross-sectional analysis of pediatric (6-17 years) mental and behavioral health ED visits using the National Hospital Ambulatory Medical Care Survey, 2006-2019. We describe administration of psychotropic medications by medication type, diagnosis, and over time. Using multivariable survey-weighted logistic regression, we examine associations between medication administration and sociodemographics.
RESULTS: A psychotropic medication was administered in 11.4% of the estimated 11,792,860 pediatric mental and behavioral health ED visits in our sample. Benzodiazepines were administered most frequently (4.9% of visits). Visits with anxiety disorders had the highest frequency of psychotropic medication use (26.7%). Visits by Black non-Hispanic patients had a 60% decreased odds of medication administration compared to visits for White non-Hispanic patients. Visits with public compared to private insurance had a 3.5 times increased odds of psychotropic polypharmacy. The proportion of visits in which a psychotropic medication was administered did not change statistically over time.
CONCLUSIONS: A psychotropic medication was administered in 1 in 10 pediatric mental and behavioral health ED visits. Use differed by sociodemographics but did not change over time. As more youth seek mental and behavioral health care in the ED, we must better understand appropriate medication use to ensure quality and equitable care.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Academic pediatrics - 23(2023), 5 vom: 10. Juli, Seite 971-979 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nash, Katherine A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Emergency medicine |
|---|
| Anmerkungen: |
Date Completed 10.07.2023 Date Revised 12.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.acap.2022.11.016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350062846 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350062846 | ||
| 003 | DE-627 | ||
| 005 | 20240312232949.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.acap.2022.11.016 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1324.xml |
| 035 | |a (DE-627)NLM350062846 | ||
| 035 | |a (NLM)36494030 | ||
| 035 | |a (PII)S1876-2859(22)00575-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nash, Katherine A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Psychotropic Medication Use in United States Pediatric Emergency Department Visits |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.07.2023 | ||
| 500 | |a Date Revised 12.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a OBJECTIVE AND BACKGROUND: Little is known about pediatric psychotropic medication use in the emergency department (ED), despite a rise in mental and behavioral health visits. This study describes psychotropic medication use in a nationally representative sample of pediatric mental and behavioral health ED visits over a 14-year period | ||
| 520 | |a METHODS: We conducted a cross-sectional analysis of pediatric (6-17 years) mental and behavioral health ED visits using the National Hospital Ambulatory Medical Care Survey, 2006-2019. We describe administration of psychotropic medications by medication type, diagnosis, and over time. Using multivariable survey-weighted logistic regression, we examine associations between medication administration and sociodemographics | ||
| 520 | |a RESULTS: A psychotropic medication was administered in 11.4% of the estimated 11,792,860 pediatric mental and behavioral health ED visits in our sample. Benzodiazepines were administered most frequently (4.9% of visits). Visits with anxiety disorders had the highest frequency of psychotropic medication use (26.7%). Visits by Black non-Hispanic patients had a 60% decreased odds of medication administration compared to visits for White non-Hispanic patients. Visits with public compared to private insurance had a 3.5 times increased odds of psychotropic polypharmacy. The proportion of visits in which a psychotropic medication was administered did not change statistically over time | ||
| 520 | |a CONCLUSIONS: A psychotropic medication was administered in 1 in 10 pediatric mental and behavioral health ED visits. Use differed by sociodemographics but did not change over time. As more youth seek mental and behavioral health care in the ED, we must better understand appropriate medication use to ensure quality and equitable care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a emergency medicine | |
| 650 | 4 | |a emergency service | |
| 650 | 4 | |a health equity | |
| 650 | 4 | |a mental and behavioral health | |
| 650 | 7 | |a Psychotropic Drugs |2 NLM | |
| 700 | 1 | |a Olfson, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Rothenberg, Craig |e verfasserin |4 aut | |
| 700 | 1 | |a Anderson, Brett R |e verfasserin |4 aut | |
| 700 | 1 | |a Pincus, Harold Alan |e verfasserin |4 aut | |
| 700 | 1 | |a Venkatesh, Arjun K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Academic pediatrics |d 2009 |g 23(2023), 5 vom: 10. Juli, Seite 971-979 |w (DE-627)NLM187486476 |x 1876-2867 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:5 |g day:10 |g month:07 |g pages:971-979 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.acap.2022.11.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 5 |b 10 |c 07 |h 971-979 | ||